Insights On Pharmaceutical Production

31. The Automation Advantage: Reducing Risk In Cell Therapy Production 8/29/2026

    Automated bioprocessing platforms transform complex cell therapy workflows into scalable, fully compliant manufacturing pathways to lower costs and expand access.

32. A Transient Cell Line To Produce rAAV With Low-Level hcDNA Encapsidation 1/15/2025

    Discover the ability of a novel HEK293 suspension cell line for efficient and scalable rAAV production across various serotypes with low encapsidated host cell DNA levels.

33. Comparing Serum-free To Serum-Supplemented Media 6/9/2025

    Reducing serum in vaccine manufacturing is a key consideration for lowering costs and improving supply security. We compare performance in serum-free versus serum-supplemented media.

34. Imagine The Future: An Enhanced Oligonucleotide Synthesis Process 2/9/2026

    Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.

35. Ingress Leak Test For Bioprocess Containers 5/28/2025

    When a visual inspection with magnification isn't enough, the IPA ingress test can definitively confirm a leak. Learn how to perform this critical quality test.

36. Release, Redefined: QC Testing Across In Vivo And Ex Vivo CAR-T 7/13/2026

    As CAR-T manufacturing evolves, QC strategies must adapt. Learn how identity, potency, sterility, and safety testing support faster release decisions and broader patient access.

37. Ensure Stability And Safety Of Your Vaccine Formulations 7/2/2026

    Optimize vaccine production with integrated manufacturing, analytical testing, containment solutions, and automated inspection for efficient, reliable scale-up.

38. Transitioning Your Product From Phase 1 To Phase 2 Clinical Studies 12/13/2024

    Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements.

39. Accelerate Your pDNA And mRNA Process Development 11/13/2025

    Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

40. Cost Modeling Analysis Of AAV And LV Manufacturing 3/31/2026

    Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.